Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Comparison of different lymphocytes in PE and control groups

From: Expression of the immune checkpoint molecules CD226 and TIGIT in preeclampsia patients

   

Control group

 

PE group

P value

CD4+ /CD3+T cell (%)

  

47.52 ± 10.58

 

52.49 ± 6.91

0.0604

CD8+ /CD3+T cell (%)

  

34.87 ± 8.41

 

33.30 ± 7.74

0.5044

CD25+CD127low/CD4+ T cell (%)

  

7.48 ± 1.71

 

6.43 ± 1.77

0.0420

  1. Note Parameters in the table are expressed as mean ± standard deviation and data between two groups were analyzed by t-test. The expression of three molecules on peripheral blood immune cells was tested by flow cytometry and the level of CD155 in serum was tested by ELISA
Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us